Leonardo Calza

4.5k total citations
197 papers, 2.7k citations indexed

About

Leonardo Calza is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Leonardo Calza has authored 197 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Infectious Diseases, 92 papers in Emergency Medicine and 59 papers in Virology. Recurrent topics in Leonardo Calza's work include HIV-related health complications and treatments (90 papers), HIV/AIDS drug development and treatment (87 papers) and HIV Research and Treatment (57 papers). Leonardo Calza is often cited by papers focused on HIV-related health complications and treatments (90 papers), HIV/AIDS drug development and treatment (87 papers) and HIV Research and Treatment (57 papers). Leonardo Calza collaborates with scholars based in Italy, United States and Netherlands. Leonardo Calza's co-authors include Roberto Manfredi, Francesco Chiodo, Vincenzo Colangeli, Pierluigi Viale, Daria Pocaterra, Marco Borderi, Isabella Bon, Maria Carla Re, Gabriella Verucchi and Filippo Trapani and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of the American Academy of Dermatology.

In The Last Decade

Leonardo Calza

183 papers receiving 2.6k citations

Peers

Leonardo Calza
Antonio Di Biagio Italy
Daniel E. Nixon United States
Ian Woolley Australia
Fehmida Visnegarwala United States
Matti Ristola Finland
Waldo Belloso Argentina
Joaquín Portilla Spain
Stéphane De Wit Belgium
Gilbert R. Kaufmann Australia
Stéphane De Wit Belgium
Antonio Di Biagio Italy
Leonardo Calza
Citations per year, relative to Leonardo Calza Leonardo Calza (= 1×) peers Antonio Di Biagio

Countries citing papers authored by Leonardo Calza

Since Specialization
Citations

This map shows the geographic impact of Leonardo Calza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonardo Calza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonardo Calza more than expected).

Fields of papers citing papers by Leonardo Calza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonardo Calza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonardo Calza. The network helps show where Leonardo Calza may publish in the future.

Co-authorship network of co-authors of Leonardo Calza

This figure shows the co-authorship network connecting the top 25 collaborators of Leonardo Calza. A scholar is included among the top collaborators of Leonardo Calza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonardo Calza. Leonardo Calza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calza, Leonardo, et al.. (2025). Decrease in drug-drug interactions between antiretroviral drugs and concomitant therapies in older people living with HIV-1 switching to bictegravir/emtricitabine/tenofovir alafenamide.. PubMed. 48(1). 70–77.
2.
3.
Monforte, Antonella d’Arminio, Iuri Fanti, Carlo Federico Perno, et al.. (2024). OC-66 Socio-demographic, clinical and therapeutic features of persons with HIV (PWH) currently in care in Italy: data from the ICONA cohort. A64–A65.
4.
Galli, Laura, Roberta Gagliardini, Filippo Lagi, et al.. (2024). Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors. BMJ Open. 14(2). e080606–e080606. 6 indexed citations
5.
6.
Calza, Leonardo, Marco Borderi, Vincenzo Colangeli, et al.. (2020). Short Communication: No Significant Changes in Weight and Body Fat Mass in Suppressed HIV-Infected Patients Switched to Dual Combination Lamivudine Plus Dolutegravir or Raltegravir. AIDS Research and Human Retroviruses. 37(3). 204–206. 6 indexed citations
7.
Calza, Leonardo, et al.. (2020). Short Communication: No Significant Increase in Body Fat Mass in Naive HIV-Infected Patients Starting Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine. AIDS Research and Human Retroviruses. 37(1). 11–15. 1 indexed citations
8.
Palermo, Federica, et al.. (2018). Lipidomics and Nutrylipidomics in Oncology: Review of the Literature. Zenodo (CERN European Organization for Nuclear Research). 1(1). 2 indexed citations
9.
10.
Magnani, G., Isabella Bon, Serena Longo, et al.. (2016). HIV-1 early and late diagnosis in the Emilia Romagna Region (Italy): a three year study.. PubMed. 39(4). 241–246. 3 indexed citations
11.
Calza, Leonardo, Vincenzo Colangeli, Isabella Bon, et al.. (2016). Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy. AIDS Research and Human Retroviruses. 33(2). 126–132. 15 indexed citations
12.
Maggi, Paolo, Vincenzo Montinaro, Cristina Mussini, et al.. (2015). Novel antiretroviral drugs and renal function monitoring of HIV patients.. PubMed. 16(3). 144–51. 33 indexed citations
13.
Calza, Leonardo, Vincenzo Colangeli, Roberto Manfredi, et al.. (2015). Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients. Infectious Diseases. 47(9). 625–636. 8 indexed citations
14.
Calcagno, Andrea, Chiara Montrucchio, Amedeo Capetti, et al.. (2015). Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics. Current HIV Research. 14(1). 54–60. 6 indexed citations
15.
Manfredi, Roberto, Leonardo Calza, Alessandra Cascavilla, et al.. (2014). Raltegravir use prospectively assessed in a major HIV outpatient clinic in Italy: sample population, virological-immunological activity, and tolerability profile.. PubMed. 22(4). 288–95. 1 indexed citations
16.
Manfredi, Roberto & Leonardo Calza. (2009). The risk of myocardial infarction during HIV infection treated with antiretroviral combinations. A review. Redalyc (Universidad Autónoma del Estado de México). 4(4). 86–104. 3 indexed citations
17.
Manfredi, Roberto & Leonardo Calza. (2007). Severe brain co-infection with Cryptococcus neoformans and Mycobacterium tuberculosis in a young, otherwise healthy student recently immigrated from China. International Journal of Infectious Diseases. 12(4). 438–441. 20 indexed citations
18.
Manfredi, Roberto, Leonardo Calza, & Francesco Chiodo. (2004). Immigration, HIV infection, and antiretroviral therapy in Italy. An epidemiological and clinical survey.. PubMed. 12(4). 219–26.
19.
Calza, Leonardo, Roberto Manfredi, & Francesco Chiodo. (2002). Use of Fibrates in the Management of Hyperlipidemia in HIV-Infected Patients Receiving HAART. Infection. 30(1). 26–31. 61 indexed citations
20.
Calza, Leonardo, et al.. (2001). American cutaneous leishmaniasis as a rare imported disease in Europe: A case report favourably treated with antimonial derivatives. European Journal of Epidemiology. 17(8). 793–795. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Di Biagio Breakdown of academic impact, for papers by Daniel E. Nixon Breakdown of academic impact, for papers by Ian Woolley Breakdown of academic impact, for papers by Fehmida Visnegarwala Breakdown of academic impact, for papers by Matti Ristola Breakdown of academic impact, for papers by Waldo Belloso Breakdown of academic impact, for papers by Joaquín Portilla Breakdown of academic impact, for papers by Stéphane De Wit Breakdown of academic impact, for papers by Gilbert R. Kaufmann Breakdown of academic impact, for papers by Stéphane De Wit
Rankless by CCL
2026